Test Code FFTYC Collagen Type II antibody
Reporting Name
Collagen Type II AntibodiesPerforming Laboratory
IMMCO Diagnostics, Inc.Specimen Type
SerumSpecimen Required
Collection Container/Tube:
Preferred: Red top
Acceptable: Serum gel
Submission Container/Tube: Plastic vial
Specimen Volume: 3 mL
Collection Instructions:
1. Draw blood in plain, red-top tube(s) or serum-gel tube(s).
2. Centrifuge and aliquot serum into a plastic vial.
3. Send refrigerated.
Specimen Minimum Volume
1 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Serum | Refrigerated (preferred) | 7 days |
| Frozen | 365 days |
Reference Values
Negative: <20 EU/mL
Borderline/Equivocal: 20-25 EU/mL
Positive: >25 EU/mL
Day(s) Performed
Once Weekly
Test Classification
This test has been developed and performance parameters have been validated by IMMCO Diagnostics, Inc. This test has not been approved by the U.S. Food and Drug Administration (FDA); however, US FDA approval is not required for clinical use. It is not intended that clinical diagnosis and patient management decisions be made using these results alone. This test has been validated using serum samples. The manufacturer has not determined the efficacy of this test when performed on CSF, plasma, joint or pleural fluid specimens. The performance characteristics of this test were determined by IMMCO Diagnostics Inc.CPT Code Information
83520
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| FFTYC | Collagen Type II Antibodies | 13879-2 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| Z0911 | Collagen Type II Antibodies | 13879-2 |
Report Available
4 to 18 daysInterpretation
Anti-collagen II antibodies occur in 22% of patients with idiopathic SNHL, 30% of patients with sudden deafness and 20% of patients with Meniere’s disease. Anti-collagen II antibodies also occur in patients with relapsing polychondritis and in rheumatoid arthritis.
Method Name
Enzyme Linked Immunosorbent Assay (ELISA)